DR.MAX secures contract for Antineoplastic and immunomodulating agents Framework agreement for the supply of drugs PN Multiple Sclerosis

Romania, March 18 -- Romania based DR.MAX has secured contract from Operator SEAP for Antineoplastic and immunomodulating agents Framework agreement for the supply of drugs PN Multiple Sclerosis. The value of the contract is worth 272396 RON.

Published by HT Digital Content Services with permission from Pivotal Sources....